help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koszewski, N. J.
Right arrow Articles by Russell, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koszewski, N. J.
Right arrow Articles by Russell, J.
Molecular Endocrinology 13 (3): 455-465
Copyright © 1999 by The Endocrine Society

Turning a Negative into a Positive: Vitamin D Receptor Interactions with the Avian Parathyroid Hormone Response Element

Nicholas J. Koszewski, Sheila Ashok and John Russell

Department of Internal Medicine (N.J.K.) Division of Nephrology, Bone and Mineral Metabolism University of Kentucky Medical Center Lexington, Kentucky 40536-0084
Department of Medicine (S.A., J.R.) Albert Einstein College of Medicine Bronx, New York 10021

1,25-Dihydroxyvitamin D3 [1,25-(OH)2D3] negatively regulates expression of the avian PTH (aPTH) gene transcript, and a vitamin D response element (VDRE) near the promoter of the aPTH gene had previously been identified. The present report assessed whether the negative activity imparted by the aPTH VDRE could be converted to a positive transcriptional response through selective mutations introduced into the element. The tested sequences were derived from individual and combined mutations to 2 bp in the 3'-half of the direct repeat element, GGGTCAggaGGGTGT. Cold competition experiments using mutant and wild-type oligonucleotides in the mobility shift assay revealed minor differences in the ability of any of these sequences to compete for binding to a heterodimer complex comprised of recombinant proteins. Ethylation interference footprint analysis for each of the mutants produced unique patterns over the 3'-half-sites that were distinct from the weak, wild-type footprint. Transcriptional outcomes evaluated from a chloramphenicol acetyltransferase reporter construct utilizing the aPTH promoter found that the individual T->A mutant produced an attenuated negative transcriptional response while the G->C mutant resulted in a reproducibly weak positive transcriptional outcome. The double mutant, however, yielded a 4-fold increase in transcription, similar to the 7-fold increase observed from an analogous construct using the human osteocalcin VDRE. UV light cross-linking to gapped oligonucleotides assessed the polarity of heterodimer binding to the wild-type and double mutant sequences and was consistent with the vitamin D receptor preferentially binding to the 5'-half of both elements. Finally, DNA affinity chromatography was used to immobilize heterodimer complexes bound to the wild-type and double mutant sequences as bait to identify proteins that may preferentially interact with these DNA-bound heterodimers. This analysis revealed the presence of a p160 protein that specifically interacted with the heterodimer bound to the wild-type VDRE, but was absent from complexes bound to response elements associated with positive transcriptional activity. Thus, the sequence of the individual VDRE appears to play an active role in dictating transcriptional responses that may be mediated by altering the ability of a vitamin D receptor heterodimer to interact with accessory factor proteins.




This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
H. Du, G. S. Daftary, S. I. Lalwani, and H. S. Taylor
Direct Regulation of HOXA10 by 1,25-(OH)2D3 in Human Myelomonocytic Cells and Human Endometrial Stromal Cells
Mol. Endocrinol., September 1, 2005; 19(9): 2222 - 2233.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
K. R McGaffin and S. A Chrysogelos
Identification and characterization of a response element in the EGFR promoter that mediates transcriptional repression by 1,25-dihydroxyvitamin D3 in breast cancer cells
J. Mol. Endocrinol., August 1, 2005; 35(1): 117 - 133.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
J.-N. Bastie, N. Balitrand, F. Guidez, I. Guillemot, J. Larghero, C. Calabresse, C. Chomienne, and L. Delva
1{alpha},25-Dihydroxyvitamin D3 Transrepresses Retinoic Acid Transcriptional Activity via Vitamin D Receptor in Myeloid Cells
Mol. Endocrinol., November 1, 2004; 18(11): 2685 - 2699.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. P. Alimov, M. C. Langub, H. H. Malluche, and N. J. Koszewski
Sp3/Sp1 in the Parathyroid Gland: Identification of an Sp1 Deoxyribonucleic Acid Element in the Parathyroid Hormone Promoter
Endocrinology, July 1, 2003; 144(7): 3138 - 3147.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G.-J. C. M. van den Bemd, M. Jhamai, A. Staal, A. J. van Wijnen, J. B. Lian, G. S. Stein, H. A. P. Pols, and J. P. T. M. van Leeuwen
A Central Dinucleotide within Vitamin D Response Elements Modulates DNA Binding and Transactivation by the Vitamin D Receptor in Cellular Response to Natural and Synthetic Ligands
J. Biol. Chem., April 19, 2002; 277(17): 14539 - 14546.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
P. POLLY, M. HERDICK, U. MOEHREN, A. BANIAHMAD, T. HEINZEL, and C. CARLBERG
VDR-Alien: a novel, DNA-selective vitamin D3 receptor-corepressor partnership
FASEB J, July 1, 2000; 14(10): 1455 - 1463.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1999 by The Endocrine Society